Variety in bone marrow F-18-FDG uptake in Hodgkin lymphoma patients without lymphomatous bone marrow involvement: does it have an explanation?

Publication date

2016-01

Authors

Adams, Hugo J. A.
de Klerk, John M. H.
Fijnheer, Rob
Heggelman, Ben G. F.
Dubois, Stefan V.
Nievelstein, Rutger A JORCID 0000-0002-0484-1486ISNI 0000000396635328
Kwee, Thomas CISNI 0000000387457697

Editors

Advisors

Supervisors

Document Type

Article

Collections

Open Access logo

License

taverne

Abstract

ObjectiveTo directly correlate fluorine-18 fluoro-2-deoxy-d-glucose (F-18-FDG) uptake of the iliac crest, as determined with PET, with both spatially matched histological bone marrow parameters and laboratory markers in Hodgkin lymphoma patients without lymphomatous bone marrow involvement at bone marrow biopsy.Materials and methodsThis retrospective study included 21 patients with newly diagnosed Hodgkin lymphoma who underwent F-18-FDG-PET and who had a lymphoma-negative bone marrow biopsy of the right posterior iliac crest. F-18-FDG-PET maximum standardized uptake value (SUVmax) was measured in the right posterior iliac crest and correlated to histological bone marrow parameters (cellularity, myeloid/erythroid ratio, degree of fibrosis, and reactive T- and B-lymphocytes) and laboratory markers (hemoglobin, C-reactive protein lactate dehydrogenase, and leukocyte and thrombocyte counts) using Pearson's correlation coefficient (R) for Gaussian data or Kendall's tau () for non-Gaussian data.ResultsThere was a significant moderate correlation between F-18-FDG-PET SUVmax and cellularity of the iliac crest (R=0.519, P=0.016). Furthermore, there was a significant strong inverse correlation between F-18-FDG-PET SUVmax of the iliac crest and hemoglobin level (R=-0.661, P=0.001) and there was a significant moderate correlation between F-18-FDG-PET SUVmax of the iliac crest and C-reactive protein level (=0.441, P=0.007). All other correlations, including F-18-FDG-PET SUVmax of the right iliac crest versus reactive T- and B-lymphocytes in the bone marrow, were not significant.ConclusionThe observations suggest increased bone marrow F-18-FDG uptake to be caused by red marrow hyperplasia because of anemia in Hodgkin lymphoma. Increased bone marrow F-18-FDG uptake is unlikely to be caused by inflammatory bone marrow changes.

Keywords

biopsy, bone marrow, F-18-FDG-PET, Hodgkin, laboratory, lymphoma, RESPONSE ASSESSMENT, FDG-PET/CT, METAANALYSIS, CONSENSUS, BIOPSY, Taverne, Journal Article, Research Support, Non-U.S. Gov't

Citation

Adams, H J A, de Klerk, J M H, Fijnheer, R, Heggelman, B G F, Dubois, S V, Nievelstein, R A J & Kwee, T C 2016, 'Variety in bone marrow F-18-FDG uptake in Hodgkin lymphoma patients without lymphomatous bone marrow involvement : does it have an explanation?', Nuclear Medicine Communications, vol. 37, no. 1, pp. 23-29. https://doi.org/10.1097/MNM.0000000000000400